Coloplast A-S Aktie
| 77,06EUR | 0,58EUR | 0,76% |
WKN DE: A1KAGC / ISIN: DK0060448595
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 12 874 | 14 572 | 15 692 | 16 639 | 16 907 |
| Umsatz pro Mitarbeiter in Mio. EUR | 1,51 | 1,55 | 1,56 | 1,62 | 1,65 |
Bilanz (in Mio. DKK) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 6 994 | 8 772 | 9 937 | 10 444 | 10 453 |
| Summe Anlagevermögen | 8 847 | 26 184 | 38 222 | 37 629 | 37 914 |
| Summe Aktiva | 15 841 | 34 956 | 48 159 | 48 073 | 48 367 |
Bilanz (in Mio. DKK) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 7 673 | 26 664 | 30 860 | 30 131 | 32 245 |
| Summe Eigenkapital | 8 168 | 8 292 | 17 299 | 17 942 | 16 122 |
| Summe Passiva | 15 841 | 34 956 | 48 159 | 48 073 | 48 367 |
Adresse
| Holtedam 1-3, 3050 Humlebaek | |
| Internet | http://www.coloplast.com |
Management
|
Aleksandra Dimovska
Senior Director-Investor Relations |
|
Allan Rasmussen
Executive Vice President-Global Operations |
|
Anders Lonning-Skovgaard
Chief Financial Officer & Executive Vice President |
|
Annette Brüls
Independent Director |
|
Caroline Vagner Rosenstand
Executive Vice President-Voice & Respiratory Care |
|
Carsten Hellmann
Independent Director |
|
Dorthe Ronnau
Executive Vice President-People & Culture |
|
Jette Nygaard-Andersen
Chairman |
|
Lars Søren Rasmussen
President, Chief Executive Officer & Director |
|
Marianne Wiinholt
Independent Director |
|
Nicolai Buhl Andersen
Executive Vice President-Chronic Care |
|
Niels Peter Louis-Hansen
Deputy Chairman |
|
Nikolaj Kyhe Gundersen
Director |
|
Roland Vendelbo Pedersen
Director |
|
Thomas Barfod
Director & Senior Controller |
|
Ulrik Berthelsen
Vice President & General Manager-UK & Ireland |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.